How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
Buchanan Ingersoll P.C., Washington, D.C., USA.
Barbara Ann
BA
Binzak
D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D017327:Clinical Trials, Phase IV as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics; D010597:Pharmacogenetics / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration